Influence of Systemic Inflammatory Response to Appearance of New Foci of Chronic Inflammation

1. Arnardottir HH, Dalli J, Norling LV, Colas RA et al. Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation. J Immunol 2016; 197(6):2362-2368.10.4049/jimmunol.1502268501100627534559Search in Google Scholar

2. Barden AE, Moghaddami M, Mas E et al. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukot Essent Fatty Acids 2016; 107:24-29.10.1016/j.plefa.2016.03.00427033423Search in Google Scholar

3. Benvenuti M, An T, Amaro E et al. Double-Edged Sword: Musculoskeletal Infection Provoked Acute Phase Response in Children. Orthop Clin North Am. 2017; 48(2):181-197.10.1016/j.ocl.2016.12.00928336041Search in Google Scholar

4. Buckley CD, Gilroy DW, Serhan CN. Pro-Resolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014; 40(3):315-327.10.1016/j.immuni.2014.02.009400495724656045Search in Google Scholar

5. Chiang N, Serhan CN. Structural Elucidation and Physiologic Functions of Specialized Pro-Resolving Mediators and Their Receptors. Mol Aspects Med. 2017; 58:114-129.10.1016/j.mam.2017.03.005562360128336292Search in Google Scholar

6. Cho JG, Lee A, Chang W et al. Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction. Front Immunol. 2018; 9:294.10.3389/fimmu.2018.00294582619729515588Search in Google Scholar

7. Colville-Nash PR, Scott DL. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Annals of the Rheumatic Diseases 1992; 51:919-925.10.1136/ard.51.7.91910047841378718Search in Google Scholar

8. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis. 2007; 10(3):149-66.10.1007/s10456-007-9074-017457680Search in Google Scholar

9. Díaz-Flores L, Gutiérrez R, García-Suárez MP et al. Morphofunctional basis of the different types of angio-genesis and formation of postnatal angiogenesis-related secondary structures. Madrid Histol Histopathol 2017; 32:1239-1279.Search in Google Scholar

10. DiPietro LA. Angiogenesis and wound repair: when enough is enough. Jornal of leukocyte biology 2016; 100(5), 979-984.10.1189/jlb.4MR0316-102R660806627406995Search in Google Scholar

11. Elshabrawy HA, Chen Z, Volin MV et al. The Pathogenic Role of Angiogenesis in Rheumatoid Arthritis. Angiogenesis. 2015; 18(4):433-448.10.1007/s10456-015-9477-2487988126198292Search in Google Scholar

12. Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis. Am J Pathol 2017; 187(6):1211-1221.10.1016/j.ajpath.2017.01.018Search in Google Scholar

13. Majno G. Chronic Inflammation. Am J Pathol 1998; 153(4):1035-1039.10.1016/S0002-9440(10)65648-9Search in Google Scholar

14. Moshage H. Cytokines and the hepatic acute phase response. Journal of Pathology 1997; vol. 181:257-266.10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-USearch in Google Scholar

15. Nathan C, Ding A. Review: Nonresolving Inflammation. Cell 2010; 140, 871-882.10.1016/j.cell.2010.02.029Search in Google Scholar

16. Orlowsky EW, Kraus VB. The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes on the Offensive. J Rheumatol 2015; 42(3):363-371.10.3899/jrheum.140382Search in Google Scholar

17. Ridiandries A, Tan JTM, Bursill CA. The Role of Chemokines in Wound Healing. Int J Mol Sci 2018; 19(10), 3217.10.3390/ijms19103217Search in Google Scholar

18. Roemer FW. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 2011; 70(10):1804-1809.10.1136/ard.2011.150243Search in Google Scholar

19. Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol 2008; 20(5):565-72.Search in Google Scholar

20. Scheibner KA, Lutz MA, Boodoo S et al. Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2. J Immunol 2006; 177 (2) 1272-1281.10.4049/jimmunol.177.2.1272Search in Google Scholar

21. Senger DR, Davis GE. Angiogenesis Cold Spring Harb Perspect. Biol 2011; 3(8):a005090.10.1101/cshperspect.a005090Search in Google Scholar

22. Serhan C.N. Novel Pro-Resolving Lipid Mediators in Inflammation Are Leads for Resolution Physiology. Nature 2014; 510(7503):92-101.10.1038/nature13479Search in Google Scholar

23. Serhan CN, Yacoubian S, Yang R. Anti-Inflammatory and Pro-Resolving Lipid Mediators. Annu Rev Pathol 2008; 3:279-312.10.1146/annurev.pathmechdis.3.121806.151409Search in Google Scholar

24. Serhan CN, Chiang N, Dalli J. The Resolution Code of Acute Inflammation: Novel Pro-Resolving Lipid Mediators in Resolution. Semin Immunol 2015; 27(3):200-215.10.1016/j.smim.2015.03.004Search in Google Scholar

25. Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J 2017; 31(4):1273-1288.10.1096/fj.201601222RSearch in Google Scholar

26. Thurston G, Murphy TJ, Baluk P et al. Angiogenesis in Mice with Chronic Airway Inflammation. Am J Pathol 1998; 153(4):1099-1112.10.1016/S0002-9440(10)65654-4Search in Google Scholar

27. Uddin M, Levy BD. Resolvins: Natural Agonists for Resolution of Pulmonary Inflammation. Prog Lipid Res 2011n; 50(1):75-88.10.1016/j.plipres.2010.09.002301213920887750Search in Google Scholar

28. Van Caam A, Vonk M, van den Hoogen F et al. Unraveling SSc Pathophysiology; The Myofibroblast. Frontiers in Immunology 2018; 9(2452):1-22.10.3389/fimmu.2018.02452624295030483246Search in Google Scholar